267 related articles for article (PubMed ID: 11443562)
1. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.
Boeckh M; Berrey MM; Bowden RA; Crawford SW; Balsley J; Corey L
J Infect Dis; 2001 Aug; 184(3):350-4. PubMed ID: 11443562
[TBL] [Abstract][Full Text] [Related]
2. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
[TBL] [Abstract][Full Text] [Related]
3. Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation.
Peck AJ; Corey L; Boeckh M
Clin Infect Dis; 2004 Sep; 39(5):673-80. PubMed ID: 15356782
[TBL] [Abstract][Full Text] [Related]
4. Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement.
Seo S; Campbell AP; Xie H; Chien JW; Leisenring WM; Englund JA; Boeckh M
Biol Blood Marrow Transplant; 2013 Apr; 19(4):589-96. PubMed ID: 23298855
[TBL] [Abstract][Full Text] [Related]
5. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
[TBL] [Abstract][Full Text] [Related]
6. Restrictive Palivizumab Use Does Not Lead to Increased Morbidity and Mortality in Pediatric Hematopoietic Stem Cell Transplantation Patients.
Teusink-Cross A; Davies SM; Danziger-Isakov L; El-Bietar J; Grimley MS
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1904-1906. PubMed ID: 27422147
[TBL] [Abstract][Full Text] [Related]
7. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
[TBL] [Abstract][Full Text] [Related]
8. Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection.
Sáez-Llorens X; Moreno MT; Ramilo O; Sánchez PJ; Top FH; Connor EM;
Pediatr Infect Dis J; 2004 Aug; 23(8):707-12. PubMed ID: 15295219
[TBL] [Abstract][Full Text] [Related]
9. Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation.
de Fontbrune FS; Robin M; Porcher R; Scieux C; de Latour RP; Ferry C; Rocha V; Boudjedir K; Devergie A; Bergeron A; Gluckman E; Azoulay E; Lapalu J; Socié G; Ribaud P
Clin Infect Dis; 2007 Oct; 45(8):1019-24. PubMed ID: 17879919
[TBL] [Abstract][Full Text] [Related]
10. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract.
Wu H; Pfarr DS; Johnson S; Brewah YA; Woods RM; Patel NK; White WI; Young JF; Kiener PA
J Mol Biol; 2007 May; 368(3):652-65. PubMed ID: 17362988
[TBL] [Abstract][Full Text] [Related]
11. A review of palivizumab and emerging therapies for respiratory syncytial virus.
Shadman KA; Wald ER
Expert Opin Biol Ther; 2011 Nov; 11(11):1455-67. PubMed ID: 21831008
[TBL] [Abstract][Full Text] [Related]
12. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation.
Shah JN; Chemaly RF
Blood; 2011 Mar; 117(10):2755-63. PubMed ID: 21139081
[TBL] [Abstract][Full Text] [Related]
13. Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab.
Kassis C; Champlin RE; Hachem RY; Hosing C; Tarrand JJ; Perego CA; Neumann JL; Raad II; Chemaly RF
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1265-71. PubMed ID: 20304082
[TBL] [Abstract][Full Text] [Related]
14. Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. The MEDI-493 Study Group.
Sáez-Llorens X; Castaño E; Null D; Steichen J; Sánchez PJ; Ramilo O; Top FH; Connor E
Pediatr Infect Dis J; 1998 Sep; 17(9):787-91. PubMed ID: 9779762
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
16. Palivizumab prophylaxis to prevent respiratory syncytial virus mortality after pediatric bone marrow transplantation: a decision analysis model.
Thomas NJ; Hollenbeak CS; Ceneviva GD; Geskey JM; Young MJ
J Pediatr Hematol Oncol; 2007 Apr; 29(4):227-32. PubMed ID: 17414564
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.
Small TN; Casson A; Malak SF; Boulad F; Kiehn TE; Stiles J; Ushay HM; Sepkowitz KA
Bone Marrow Transplant; 2002 Feb; 29(4):321-7. PubMed ID: 11896429
[TBL] [Abstract][Full Text] [Related]
18. Intravenous palivizumab in respiratory syncytial virus infection after hematopoietic stem cell transplant in children.
Torres JP; Tapia LI; Catalán P; De la Maza V; Mejías A
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598593
[TBL] [Abstract][Full Text] [Related]
19. Detection, control, and management of a respiratory syncytial virus outbreak in a pediatric hematology-oncology department.
Shachor-Meyouhas Y; Zaidman I; Kra-Oz Z; Arad-Cohen N; Kassis I
J Pediatr Hematol Oncol; 2013 Mar; 35(2):124-8. PubMed ID: 23128340
[TBL] [Abstract][Full Text] [Related]
20. Prevention of respiratory syncytial virus infection among Puerto Rican infants.
Winchester L; García L; García I; Concepción CB
P R Health Sci J; 2002 Sep; 21(3):191-3. PubMed ID: 12243108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
